Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Machine Learning Maps Immune Responses to Revolutionize Sepsis Care
Tech & Innovation Machine Learning Maps Immune Responses to Revolutionize Sepsis Care

The discovery of the STImS framework suggests that the 'one size fits all' approach to treating systemic inflammation is no longer sufficient for modern critical care. Sepsis remains a formidable challenge, claiming millions of lives annually through a process where the immune system inadvertently

VLP Platform Advances Precision Engineering of Myeloid Cells
Research & Development VLP Platform Advances Precision Engineering of Myeloid Cells

The SLICeVLP system decouples guide RNA delivery from Cas9 protein delivery to enable large-scale pooled CRISPR screening in primary human macrophages for the first time. This technological leap addresses a longstanding bottleneck in the field of immunotherapy, where the focus has historically

UC Davis Cancer Center Renews Prestigious NCI Designation
Research & Development UC Davis Cancer Center Renews Prestigious NCI Designation

In addition to the recent NCI renewal, the UC Davis Medical Center has maintained its ranking as the top hospital in the Sacramento area for fifteen consecutive years according to national reports. This sustained excellence reached a new milestone today as the National Cancer Institute officially

Bioengineered Conduits Show Promise for Coronary Bypass Surgery
Research & Development Bioengineered Conduits Show Promise for Coronary Bypass Surgery

A major hurdle in cardiac surgery is the compliance mismatch between stiff artificial tubes and flexible arteries, which creates turbulent blood flow and eventual graft blockage. This fundamental discrepancy has long prevented the widespread adoption of synthetic bypass grafts, as the sudden change

How Is Truveta Scaling the Learning Health System?
Tech & Innovation How Is Truveta Scaling the Learning Health System?

The convergence of big data and clinical medicine is finally enabling the creation of a system where every patient encounter contributes to collective medical knowledge. As healthcare providers grapple with the sheer volume of information generated within their networks, the ability to synthesize

Can Lab-Grown Brain Organoids Reveal the Secrets of Aging?
Biotech & Bioprocessing Can Lab-Grown Brain Organoids Reveal the Secrets of Aging?

The internal chronology of the human brain appears to be a negotiation between hardwired genetic programs and the external environment rather than a purely reactive state. This realization marks a significant departure from traditional neurobiology, which often viewed the brain as a plastic organ

Can a Metastasis-on-a-Chip Transform Cancer Research?
Biotech & Bioprocessing Can a Metastasis-on-a-Chip Transform Cancer Research?

By integrating a selectively permeable endothelial lining, this new technology forces cancer cells to demonstrate their ability to traverse vessel walls. This breakthrough represents a monumental shift in oncology, moving away from the static culture plates and animal models that have dominated

How Is COFEPRIS Digitizing Medical Device Regulation?
Management & Regulatory How Is COFEPRIS Digitizing Medical Device Regulation?

This digital initiative addresses long-standing inefficiencies by providing a public mechanism to verify the legal status of medical devices sold throughout the country. For many years, the Mexican medical device market struggled with a lack of transparency, where paper-based records led to

Can New Treatments Replace Rectal Cancer Surgery?
Research & Development Can New Treatments Replace Rectal Cancer Surgery?

International researchers have identified a five-week chemoradiotherapy protocol that allows four out of five patients to avoid major surgery while maintaining their quality of life. This paradigm shift in oncology marks a departure from the traditional approach, where radical excision was

Safe Stem Cell Transplant Methods for Cold Agglutinin Disease
Research & Development Safe Stem Cell Transplant Methods for Cold Agglutinin Disease

Standard laboratory protocols for washing and preparing harvested stem cells must be modified with pre-warmed solutions to prevent thermal shock in sensitive biological samples. This requirement becomes critically apparent when treating patients with Cold Agglutinin Disease (CAD), a rare autoimmune

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later